Committee
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 1 of 1
View Patty Hajdu Profile
Lib. (ON)
The challenge is that Vertex has not submitted an application, nor is it in negotiations with Canada to market this product. However, we do have the special access program that the member may be aware of. In fact, out of 98 patients who applied for special access to Trikafta, 95 were approved as of May 6.
Result: 1 - 1 of 1

Export As: XML CSV RSS

For more data options, please see Open Data